Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP164295.RAZEmIKhGg1dO1DmUxTQmhr3Nl6bMRfCt3iIWnalUsBcU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP164295.RAZEmIKhGg1dO1DmUxTQmhr3Nl6bMRfCt3iIWnalUsBcU130_assertion type Assertion NP164295.RAZEmIKhGg1dO1DmUxTQmhr3Nl6bMRfCt3iIWnalUsBcU130_head.
- NP164295.RAZEmIKhGg1dO1DmUxTQmhr3Nl6bMRfCt3iIWnalUsBcU130_assertion description "[results of a small sample of invasive ductal breast carcinoma patients suggest that low securin expression identifies a distinct subgroup of more favourable outcome among patients with high Ki-67 immunoexpression or high mitotic activity index ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP164295.RAZEmIKhGg1dO1DmUxTQmhr3Nl6bMRfCt3iIWnalUsBcU130_provenance.
- NP164295.RAZEmIKhGg1dO1DmUxTQmhr3Nl6bMRfCt3iIWnalUsBcU130_assertion evidence source_evidence_literature NP164295.RAZEmIKhGg1dO1DmUxTQmhr3Nl6bMRfCt3iIWnalUsBcU130_provenance.
- NP164295.RAZEmIKhGg1dO1DmUxTQmhr3Nl6bMRfCt3iIWnalUsBcU130_assertion SIO_000772 18594525 NP164295.RAZEmIKhGg1dO1DmUxTQmhr3Nl6bMRfCt3iIWnalUsBcU130_provenance.
- NP164295.RAZEmIKhGg1dO1DmUxTQmhr3Nl6bMRfCt3iIWnalUsBcU130_assertion wasDerivedFrom lhgdn-20090331 NP164295.RAZEmIKhGg1dO1DmUxTQmhr3Nl6bMRfCt3iIWnalUsBcU130_provenance.
- NP164295.RAZEmIKhGg1dO1DmUxTQmhr3Nl6bMRfCt3iIWnalUsBcU130_assertion wasGeneratedBy ECO_0000203 NP164295.RAZEmIKhGg1dO1DmUxTQmhr3Nl6bMRfCt3iIWnalUsBcU130_provenance.